PRESS RELEASE published on 09/03/2026 at 19:15, 2 months 5 days ago Inside Information / Other news releases Laure-Hélène Mercier appointed as Chair of Poxel's Board of Directors, enhancing governance and financial oversight. Sophie Jacq Lapointe steps down with gratitude. Poxel focuses on metabolic diseases and HCM treatments Governance Metabolic Diseases Poxel Laure-Hélène Mercier HCM
PRESS RELEASE published on 09/03/2026 at 19:15, 2 months 5 days ago Informations privilégiées / Autres communiqués Laure-Hélène Mercier nommée Présidente du Conseil d'administration de Poxel en remplacement de Sophie Jacq Lapointe. Renforcement de la gouvernance et du contrôle financier Gouvernance Conseil D'administration Biopharmaceutique Poxel Laure-Hélène Mercier
BRIEF published on 07/30/2026 at 21:35, 3 months 9 days ago Poxel : Résultats du 2ème trimestre 2026 et report des comptes 2025 Chiffre D'affaires TWYMEEG® Poxel Sumitomo Pharma Comptes 2025
BRIEF published on 07/30/2026 at 21:35, 3 months 9 days ago Poxel enregistre un chiffre d'affaires positif malgré le report de la publication de ses résultats financiers États Financiers Redevance Poxel Ventes TWYMEEG® Évaluation De La Dette
BRIEF published on 07/30/2026 at 21:35, 3 months 9 days ago Poxel Records Positive Turnover amidst Financial Statement Postponement Financial Statements Royalties Poxel TWYMEEG® Sales Debt Valuation
BRIEF published on 07/30/2026 at 21:35, 3 months 9 days ago Poxel: Q2 2026 Results and 2025 Financial Statements Report Revenue TWYMEEG® Poxel Sumitomo Pharma 2025 Accounts
PRESS RELEASE published on 07/30/2026 at 21:30, 3 months 9 days ago Informations privilégiées / Autres communiqués Poxel publie son chiffre d'affaires pour le deuxième trimestre 2026 et annonce le report de la publication des comptes 2025. Les ventes de TWYMEEG® au Japon en forte croissance Chiffre D'affaires Croissance Report Poxel TWYMEEG
PRESS RELEASE published on 07/30/2026 at 21:30, 3 months 9 days ago Inside Information / Other news releases Poxel publishes Q2 2026 turnover & delays 2025 financial statements release. TWYMEEG(R) net sales up in Japan, reaching 2.9 billion yen; royalty rate to increase Financial Statements Turnover Royalties Poxel TWYMEEG
BRIEF published on 06/10/2026 at 20:18, 4 months 28 days ago Poxel nomme Yves Decadt PDG pour faire progresser ses objectifs stratégiques Partenariats Stratégiques Biopharmaceutique Poxel Iméglimine Yves Decadt
BRIEF published on 06/10/2026 at 20:18, 4 months 28 days ago Poxel appoints Yves Decadt as its new Chief Executive Officer Strategic Partnerships Biopharmaceutical Continuation Plan Poxel Yves Decadt
Published on 11/06/2026 at 22:15, 2 days 1 hour ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 10 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 11 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 11 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/08/2026 at 12:10, 11 hours 41 minutes ago GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/08/2026 at 10:15, 13 hours 36 minutes ago 2026 China International Intelligent Communication Forum Held in Wuxi
Published on 11/07/2026 at 13:35, 1 day 10 hours ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 2 days 3 hours ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 2 days 3 hours ago L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:06, 2 days 4 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 2 days 4 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 2 days 4 hours ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 2 days 4 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
